Weegen Felice Isabel Verduyn-van

CIK: 0002094941

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

AGMB

Agomab Therapeutics NV

Director

EVMN

Evommune, Inc.

Director10% Owner

Discretionary Trading P&L

Holdings

Transaction History (3 total)

EVMN
Evommune, Inc.
Feb 17, 2026
Award(A)
Indirect
358.7K shares at avg. $27.88$10.0M
EVMN
Evommune, Inc.
Nov 7, 2025
Conversion(C)
Indirect
3.4M shares-
EVMN
Evommune, Inc.
Nov 7, 2025
Purchase(P)
Indirect
1.6M shares at avg. $16.00$25.0M

		Type	Shares	Price		Ownership
Feb 17, 2026	EVMN Evommune, Inc.	Award(A)	358,680	$27.88	$9,999,998	Indirect
Nov 7, 2025	EVMN Evommune, Inc.	Conversion(C)	3,367,133	-	-	Indirect
Nov 7, 2025	EVMN Evommune, Inc.	Purchase(P)	1,562,500	$16.00	$25,000,000	Indirect

1-3 of 3 transactions

About Verduyn-van Weegen Felice Isabel

Verduyn-van Weegen Felice Isabel (SEC CIK 0002094941) files insider reports with the SEC as Director of Agomab Therapeutics NV (AGMB) and Director of Evommune, Inc. (EVMN).

Signal8 holds 4 ownership filings by Verduyn-van Weegen Felice Isabel (2 Form 3, 2 Form 4), filed between Nov 5, 2025 and Mar 18, 2026. Those filings report 3 transactions, from Nov 7, 2025 to Feb 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Verduyn-van Weegen Felice Isabel's filings is in PALO ALTO, CA.

Recent filings by Verduyn-van Weegen Felice Isabel

Feb 17, 2026: Grant or award of EVMN shares (Form 4, code A).
Nov 7, 2025: Conversion of EVMN shares (Form 4, code C).
Nov 7, 2025: Open-market purchase of EVMN shares (Form 4, code P).

Other insiders filing for Agomab Therapeutics NV (AGMB)

Epstein David R, Director
Kemula Pierre Thadee Victor, Chief Financial Officer
Knotnerus Tim Jasper, Chief Executive Officer
Garcia Marino, Director
Patel Naimish, Director
Bond Colin Michael, Director

How to read Form 4 transaction codes